CA2831703A1 - Procede de preparation d'un agent antipsychotique - Google Patents

Procede de preparation d'un agent antipsychotique Download PDF

Info

Publication number
CA2831703A1
CA2831703A1 CA2831703A CA2831703A CA2831703A1 CA 2831703 A1 CA2831703 A1 CA 2831703A1 CA 2831703 A CA2831703 A CA 2831703A CA 2831703 A CA2831703 A CA 2831703A CA 2831703 A1 CA2831703 A1 CA 2831703A1
Authority
CA
Canada
Prior art keywords
formula
trans
cyclohexane
process according
dicarboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2831703A
Other languages
English (en)
Inventor
Suresh Babu Jayachandra
Udaibhan Singh Gahlot
Tarun Kumar Singh
Chandra Has Khanduri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of CA2831703A1 publication Critical patent/CA2831703A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2831703A 2011-04-01 2012-03-28 Procede de preparation d'un agent antipsychotique Abandoned CA2831703A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN943DE2011 2011-04-01
IN943/DEL/2011 2011-04-01
PCT/IB2012/051500 WO2012131606A1 (fr) 2011-04-01 2012-03-28 Procédé de préparation d'un agent antipsychotique

Publications (1)

Publication Number Publication Date
CA2831703A1 true CA2831703A1 (fr) 2012-10-04

Family

ID=45937504

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2831703A Abandoned CA2831703A1 (fr) 2011-04-01 2012-03-28 Procede de preparation d'un agent antipsychotique

Country Status (4)

Country Link
EP (1) EP2694499A1 (fr)
AU (1) AU2012235724A1 (fr)
CA (1) CA2831703A1 (fr)
WO (1) WO2012131606A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409899B2 (en) 2012-02-13 2016-08-09 Cadila Healthcare Limited Process for preparing benzisothiazol-3-yl-piperazin-1-yl-methyl-cyclo hexylmethanisoindol-1,3-dione and its intermediates
WO2014037886A1 (fr) * 2012-09-04 2014-03-13 Ranbaxy Laboratories Limited Procédé de préparation de chlorhydrate de lurasidone
CN102911170A (zh) * 2012-11-15 2013-02-06 苏州第壹制药有限公司 酰亚胺化合物盐酸盐的制备方法
CN102936243B (zh) * 2012-11-16 2015-08-05 上海伯倚化工科技有限公司 一种鲁拉西酮的合成方法
CN103864774B (zh) * 2012-12-14 2016-09-28 成都弘达药业有限公司 一种鲁拉西酮的制备方法
WO2014102808A1 (fr) 2012-12-25 2014-07-03 Lee Pharma Limited Procédé de préparation d'acide trans-(lr,2r)-cyclohexane 1,2-dicarboxylique
ITMI20130262A1 (it) * 2013-02-22 2014-08-23 Edmond Pharma Srl Procedimento per la preparazione di lurasidone cloridrato
ITMI20131245A1 (it) * 2013-07-24 2015-01-25 Olon Spa Procedimento per la produzione di lurasidone ad elevata purezza
CN104513182A (zh) * 2013-10-08 2015-04-15 无锡万全医药技术有限公司 一种(1r,2r)-1,2-环己烷二甲醇二磺酸酯的制备方法
ITMI20131737A1 (it) 2013-10-17 2015-04-18 Procos Spa Processo per la sintesi industriale di lurasidone
CN103724238A (zh) * 2013-12-31 2014-04-16 无锡万全医药技术有限公司 一种（1r,2r）-1,2-环己烷二甲醇二芳基磺酸酯的制备方法
US9790237B2 (en) 2014-06-16 2017-10-17 Johnson Matthey Public Limited Company Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates
US10426770B2 (en) 2014-10-14 2019-10-01 Jubilant Generics Limited Process for the preparation of Lurasidone hydrochloride
EP3242876A4 (fr) 2015-01-08 2019-01-02 Piramal Enterprises Limited Procédé amélioré de préparation de lurasidone et de ses intermédiaires
CN106916151A (zh) * 2015-12-28 2017-07-04 苏州二叶制药有限公司 一种盐酸鲁拉西酮的制备方法
CN106518729A (zh) * 2016-09-21 2017-03-22 北京万全德众医药生物技术有限公司 盐酸鲁拉西酮中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2800953B2 (ja) 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
JP4219696B2 (ja) 2003-01-27 2009-02-04 大日本住友製薬株式会社 光学活性トランス−１，２−シクロヘキサンジカルボン酸誘導体の製造方法
US20110003994A1 (en) 2009-07-02 2011-01-06 Dainippon Sumitomo Pharma Co., Ltd. Cycloalkane derivative

Also Published As

Publication number Publication date
WO2012131606A1 (fr) 2012-10-04
EP2694499A1 (fr) 2014-02-12
AU2012235724A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
CA2831703A1 (fr) Procede de preparation d'un agent antipsychotique
JP5410578B2 (ja) シラスタチン酸の改善された製造方法
CA2578409A1 (fr) Procedes de preparation d'irbesartan et d'intermediaires associes
US11472770B2 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
WO2014037886A1 (fr) Procédé de préparation de chlorhydrate de lurasidone
US10426770B2 (en) Process for the preparation of Lurasidone hydrochloride
US7470816B2 (en) Tramadol recovery process
JPH0859517A (ja) 光学分割剤およびそれを用いた光学活性テトラヒドロフランカルボン酸類の製造法
US8129536B2 (en) Method for the purification of lansoprazole
CA2570415C (fr) Procede ameliore pour la preparation du 5,6-dihydro-4h-4(s)-ethylamino-6(s)-methylthieno[2,3-b]thiopyrane-2-sulfonamide-7,7-dioxyde et de son sel
US20120035374A1 (en) Process for the preparation of fluvastatin and salts thereof
US9828334B2 (en) Process for preparing levomilnacipran
JP4126921B2 (ja) 光学活性なβ−フェニルアラニン誘導体の製造方法
JP4752285B2 (ja) トリフルオロ乳酸の効率的な光学分割
KR100503639B1 (ko) 탐술로신의 정제 방법
US20180029993A1 (en) Method for producing optically active valeric acid derivative
JPWO2010079605A1 (ja) 高純度１−ベンジル−３−アミノピロリジンの製造方法
JP5704182B2 (ja) 光学活性テトラヒドロフラン−２−カルボン酸の製造方法
WO2003068728A1 (fr) Procede de production de $g(b)-phenylalamine optiquement active
JP3694923B2 (ja) 光学活性 １−（２，４−ジクロロフェニル） エチルアミンの製造方法
JP5176452B2 (ja) 光学活性なテトラヒドロピラニルグリシン化合物の製造方法
JPWO2004046075A1 (ja) シクロアルキルエーテル化合物を含有してなる結晶化用溶剤及び該溶剤を用いる結晶化方法
JPH10101629A (ja) 光学活性酪酸誘導体の製造方法
JPH10195015A (ja) ２−ベンジルコハク酸化合物の光学分割方法
JP2003238513A (ja) 光学活性２−アミノペンタンニトリル塩の製造方法

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20150330